These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6892779

  • 1. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB, Dussourd d'Hinterland L.
    Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
    Michel FB, Dussourd d'Hinterland L, Pinel AM, Guendon R, Guerrero AJ, Moutou M, Bansard JP.
    Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
    [Abstract] [Full Text] [Related]

  • 3. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
    Charachon R, Lavillauroy PJ, Fumex JP.
    Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Study of the chronic toxicity of D 53 by aerosol. One-year observation.
    Fontanges R, Robert D, Isoard P.
    Arzneimittelforschung; 1980; 30(1a):187-96. PubMed ID: 6989375
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP, Michel FB.
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract] [Full Text] [Related]

  • 7. Immunomodulation of polymorphonuclear leukocytes by D53 Immucytal and its constitutive fractions.
    Minonzio F, Ongari AM, Venegoni E, Carbonelli V, Licciardello L, Capsoni F.
    Boll Ist Sieroter Milan; 1989; 68(3):241-8. PubMed ID: 2491432
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prevention of bacterial respiratory infections by ribosomal vaccines].
    Michel FB, D'Hinterland LD, Fumex JP, Guendon R.
    Bronchopneumologie; 1979; 29(4):337-42. PubMed ID: 509335
    [No Abstract] [Full Text] [Related]

  • 10. Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study.
    Béné MC, Kahl L, Perruchet AM, Hermes H, Mösges M, Normier G, Binz H, Faure GC.
    Scand J Immunol; 1993 Nov; 38(5):496-8. PubMed ID: 8235452
    [Abstract] [Full Text] [Related]

  • 11. Role of bacterial vaccines in prevention of respiratory infections with special reference to pneumococcal vaccines.
    Huchon G.
    Postgrad Med J; 1983 Nov; 59 Suppl 3():185-7. PubMed ID: 6647205
    [Abstract] [Full Text] [Related]

  • 12. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML, Arêas AP, Ho PL.
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [Abstract] [Full Text] [Related]

  • 13. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D, Fehnle K.
    Vaccine; 2008 Nov 05; 26(47):5944-51. PubMed ID: 18801402
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of infections in chronic bronchitis using vaccination and/or immunomodulation].
    Latil F, Arnaud A, Lagier F, Charpin J, Vervloet D.
    Rev Mal Respir; 1988 Nov 05; 5(1):31-5. PubMed ID: 3368632
    [Abstract] [Full Text] [Related]

  • 15. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV, Vinnikov AK.
    Vestn Otorinolaringol; 2001 Nov 05; (1):40. PubMed ID: 11247247
    [No Abstract] [Full Text] [Related]

  • 16. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M, Eckenberger HP.
    Fortschr Med; 1992 Nov 30; 110(30):565-70. PubMed ID: 1468743
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S, Tazza R.
    Arzneimittelforschung; 2004 Nov 30; 54(1):50-6. PubMed ID: 14979609
    [No Abstract] [Full Text] [Related]

  • 18. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB, d'Hinterland LD, Pinel AM, Guendon R, Guerrero A, Préault M.
    Nouv Presse Med; 1975 Feb 01; 4(5):333-6. PubMed ID: 1093123
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of a mixture of bacterial ribosomes and membrane fractions of Klebsiella pneumoniae on the development of a transplanted epithelial cancer in rats].
    Deloince R, Beaudry Y, Robert D, Barjox P, Le Pivert P, Fontanges R.
    C R Seances Soc Biol Fil; 1977 Feb 01; 171(4):819-22. PubMed ID: 145286
    [Abstract] [Full Text] [Related]

  • 20. Vaccines against bacterial meningitis.
    Segal S, Pollard AJ.
    Br Med Bull; 2004 Feb 01; 72():65-81. PubMed ID: 15802609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.